Eli Lilly to acquire Loxo Oncology for $8 billion Medical Dialogues Bureau8 Jan 2019 12:09 PM ISTWashington: -Pharmaceutical giant Eli Lilly will acquire cancer treatment specialist Loxo Oncology in a cash deal valued at around $8 billion, the...
Takeda unlikely to sell OTC drug business - CEO Medical Dialogues Bureau8 Jan 2019 9:08 AM ISTTOKYO - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it closes a...
Fighting Parkinsons: Medica Hospital to launch new treatment in eastern India Farhat Nasim7 Jan 2019 12:06 PM ISTApomorphine is a highly selective Dopamine receptor emulator, which promotes the release of Dopamine in the brain from the nerve cells, explained Dr...
Lupin receives FDA approval for Lurasidone Hydrochloride Tablets Farhat Nasim7 Jan 2019 9:45 AM ISTLupin's Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg is the generic version of Sunovion Pharmaceuticals, Inc's Latuda...
Rs 8100 crore bank loan fraud case: Sterling Biotech receives non bailable warrants Medical Dialogues Bureau7 Jan 2019 9:15 AM ISTAdditional Sessions Judge Satish Kumar Arora allowed the Enforcement Directorate's plea seeking issuance of NBW against Sterling Biotech Ltd (SBL)...
Merck KEYTRUDA receives five new approvals in Japan Farhat Nasim7 Jan 2019 9:00 AM ISTKEYTRUDA is the First Anti-PD-1 Approved in Japan for the First-Line Treatment of Advanced NSCLC as Both Monotherapy and in Combination with...
Rs 11000 crore benefit to people from fixing drug prices: Minister Medical Dialogues Bureau6 Jan 2019 9:35 AM ISTThe Minister, who was replying during the Question Hour, said that to make medicines affordable, the government capped prices of 855 medicines and...
PharmaHopers launches derma franchise category for B2B businesses Farhat Nasim6 Jan 2019 9:15 AM ISTPharmaHopers has a number of dermatology companies listed which are involved in the marketing and manufacturing of derma products like Acne and...
PMBJP Kendras: Unbranded generic medicines worth Rs 417 crore sold till 2018 Farhat Nasim5 Jan 2019 10:45 AM ISTUnbranded generic medicines worth Rs 417 crore have been sold through PMBJP Kendras from the inception of the scheme till the end of December 2018,...
Relief to Foreign Drugmakers: No price cap on innovative drugs for first five years Farhat Nasim5 Jan 2019 10:44 AM ISTNew Delhi: Through a recent Gazette notice the Central Government has made amendments to the Drugs Prices Control Orders (DPCO),2013 which aim to...
Bristol-Myers Squibb buying Celgene in Rs 7400 crores deal Farhat Nasim5 Jan 2019 9:15 AM ISTShareholders of Bristol-Myers Squibb Co, based in New York City, would own about 69 per cent of the company, with Celgene shareholders owning about 31...
Glenmark Pharma transfers API biz to Glenmark Life Sciences Farhat Nasim5 Jan 2019 9:00 AM ISTIts API biz spans more than 80 countries, including regulated markets of the US, Canada, Europe and Japan. Glenmark, which entered into the API...
